Literature DB >> 10619438

Angiotensin-converting enzyme gene I/D polymorphism and renal disease.

G Navis1, F G van der Kleij, D de Zeeuw, P E de Jong.   

Abstract

In recent years a vast amount of data has been published on the association between the insertion/deletion (I/D) polymorphism of the gene coding for angiotensin-converting enzyme and renal disease. It has become clear that the polymorphism does not affect the prevalence of renal disease. However, data on the association with progression of renal disease and therapy response are still contradictory. Moreover, sufficient data on the physiological significance of this polymorphism are still lacking. This contribution provides an overview of the available studies and the potential pitfalls in interpreting the data. We also discuss the putative mechanisms for the association between the DD genotype and progression of renal disease and suggest directions for the future that might be employed to further clarify the role in renal pathophysiology.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10619438     DOI: 10.1007/s001099900063

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  5 in total

1.  Association of TNF-α -308 G > A and ACE I/D gene polymorphisms in hemodialysis patients with arteriovenous fistula thrombosis.

Authors:  Elif Funda Sener; Serpil Taheri; Keziban Korkmaz; Gokmen Zararsiz; Faruk Serhatlioglu; Aydin Unal; Omer Naci Emirogullari; Yusuf Ozkul
Journal:  Int Urol Nephrol       Date:  2013-10-15       Impact factor: 2.370

2.  ACE I/D gene polymorphism in primary FSGS and steroid-sensitive nephrotic syndrome.

Authors:  Faruk Oktem; Aydan Sirin; Ilmay Bilge; Sevinç Emre; Bedia Ağaçhan; Turgay Ispir
Journal:  Pediatr Nephrol       Date:  2004-02-21       Impact factor: 3.714

3.  Association of angiotensin-converting enzyme gene I/D polymorphism with steroid responsiveness in childhood nephrotic syndrome.

Authors:  P Prasun; N Prasad; G Tripathi; T Jafar; S Sharda; S Gulati; S Agrawal
Journal:  Indian J Nephrol       Date:  2011-01

4.  Does the Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism modify the response to ACE inhibitor therapy?--A systematic review.

Authors:  Madlaina Scharplatz; Milo A Puhan; Johann Steurer; Annalisa Perna; Lucas M Bachmann
Journal:  Curr Control Trials Cardiovasc Med       Date:  2005-10-24

5.  What is the impact of the ACE gene insertion/deletion (I/D) polymorphism on the clinical effectiveness and adverse events of ACE inhibitors?--Protocol of a systematic review.

Authors:  M Scharplatz; M A Puhan; J Steurer; L M Bachmann
Journal:  BMC Med Genet       Date:  2004-09-10       Impact factor: 2.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.